Nitrous Oxide
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | NITROUS OXIDE, USP | — | 2013-06-16 | fda.gov ↗ |
Trials 87 · started per year
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 08 trials | ||||||
| Phase 0 | NCT07245628 | Oct 2025 → May 2028 expected | — | Alexandra J. Berger Eberhardt, MD | Recruiting | No outcome recorded |
| Phase 0 | NCT06702631 | Jan 2025 → Sep 2026 expected | amnestic disorder | Keith M Vogt | Recruiting | No outcome recorded |
| Phase 0 | NCT05579288 | Dec 2022 → Jun 2024 | — | Sheba Medical Center | Unknown | No outcome recorded |
| Phase 0 | NCT04305158 | Mar 2022 → Aug 2023 | — | University of Arkansas | Completed | No outcome recorded |
| Phase 0 | NCT06661005 | May → Sep 2021 | — | University of Arizona | Terminated | No outcome recorded |
| Phase 0 | NCT03695887 | Oct 2019 → Dec 2028 expected | — | University of Manitoba | Recruiting | No outcome recorded |
| Phase 0 | NCT02757521 | Mar → Dec 2016 | bipolar depression | Washington University School of Medicine | Terminated | No outcome recorded |
| Phase 0 | NCT02246517 | Sep 2014 → Dec 2015 | neuropathy, painful | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| Phase 15 trials | ||||||
| Phase 1 | NCT04884893 | May → Sep 2021 | — | Tampere University Hospital | Completed | No outcome recorded |
| Phase 1 | NCT03736538 | Oct 2018 → Sep 2026 expected | major depressive disorder | Washington University School of Medicine | Enrolling by invitation | No outcome recorded |
| Phase 1 | NCT02994433 | Jan 2017 → Apr 2027 expected | major depressive disorder | Washington University School of Medicine | Recruiting | No outcome recorded |
| Phase 1 | NCT01785030 | Feb 2013 → Feb 2017 | — | Columbia University | Terminated | No outcome recorded |
| Phase 1 | NCT01736020 | Sep 2009 → Apr 2017 | — | Southern California Institute for Research and Education | Unknown | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02899182 | Apr 2016 → Mar 2017 | — | Fluminense Federal University | Completed | No outcome recorded |
| Phase 214 trials | ||||||
| Phase 2 | NCT06382389 | Sep 2026 → Sep 2028 expected | cognitive disorder, depressive disorder | University Hospital, Tours | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06636357 | Jan 2025 → Sep 2026 expected | electroencephalographic peculiarity: fronto-precentral beta wave groups, hair anomaly | University of Zurich | Recruiting | No outcome recorded |
| Phase 2 | NCT06430489 | Jun 2024 → Dec 2025 | — | University Hospital, Tours | Unknown | No outcome recorded |
| Phase 2 | NCT07384988 | Jan → Aug 2024 | — | Shaoxing Maternity and Child Health Care Hospital | Completed | No outcome recorded |
| Phase 2 | NCT04378426 | Oct 2021 → Aug 2022 | post-traumatic stress disorder | VA Office of Research and Development | Terminated | No outcome recorded |
| Phase 2 | NCT03826693 | Apr 2021 → Sep 2026 expected | obsessive-compulsive disorder | Stanford University | Recruiting | No outcome recorded |
| Phase 2 | NCT03932825 | Apr 2019 → Mar 2021 | major depressive disorder | Lingjiang Li | Completed | No outcome recorded |
| Phase 2 | NCT03869736 | Jan 2019 → Jun 2023 | major depressive disorder | Bayside Health | Completed | No outcome recorded |
| Phase 2 | NCT03375294 | Apr 2018 → Jul 2019 | post-traumatic stress disorder | Stanford University | Completed | No outcome recorded |
| Phase 2 | NCT03283670 | Nov 2016 → Feb 2020 | major depressive disorder | Washington University School of Medicine | Completed | No outcome recorded |
| Phase 2 | NCT01891812 | Nov 2013 → Jan 2018 | sickle cell disease | Columbia University | Completed | No outcome recorded |
| Phase 2 | NCT02139540 | Nov 2012 → Apr 2015 | major depressive disorder | Washington University School of Medicine | Completed | No outcome recorded |
| Phase 2 | NCT01738672 | Feb 2012 → Oct 2013 | — | Ya'aqov Abrams | Terminated | No outcome recorded |
| Phase 2 | NCT00000261 | Nov 1997 → Oct 1998 | alcohol-related disorders | University of Chicago | Completed | No outcome recorded |
| Phase 2/33 trials | ||||||
| Phase 2/3 | NCT04089852 | Jun → Nov 2021 | — | Boston Children's Hospital | Withdrawn | No outcome recorded |
| Phase 2/3 | NCT03483194 | Sep 2018 → Apr 2020 | hematopoietic and lymphoid cell neoplasm | Weprom | Completed | No outcome recorded |
| Phase 2/3 | NCT00762372 | Feb → Aug 2008 | — | Baxter Healthcare Corporation | Completed | No outcome recorded |
| Phase 310 trials | ||||||
| Phase 3 | NCT06498908 | Mar 2026 | — | Olivia Sher | Withdrawn | No outcome recorded |
| Phase 3 | NCT07262008 | Feb 2026 → Feb 2027 expected | major depressive disorder | Women's College Hospital | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT05383495 | Dec 2023 → Dec 2025 overdue | — | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Recruiting | No outcome recorded |
| Phase 3 | NCT03728894 | Nov 2018 → Jan 2019 | — | Latakia University | Completed | No outcome recorded |
| Phase 3 | NCT03502915 | Jan 2017 → Feb 2019 | — | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 3 | NCT01948115 | Nov 2013 → Dec 2015 | — | Nantes University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT00643357 | Mar 2008 → Jan 2009 | — | Air Liquide | Withdrawn | No outcome recorded |
| Phase 3 | NCT00392522 | Nov 2006 → ? | — | Hospices Civils de Lyon | Unknown | No outcome recorded |
| Phase 3 | NCT00219713 | Mar 2000 → Dec 2004 | — | Poitiers University Hospital | Terminated | No outcome recorded |
| Phase 3 | NCT00250692 | — | — | University of California, Los Angeles | Withdrawn | No outcome recorded |
| Phase 422 trials | ||||||
| Phase 4 | NCT07387315 | Feb → Nov 2026 expected | overactive bladder | TriHealth Inc. | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT05895383 | May 2023 → Jan 2027 expected | anxiety | Beth Israel Deaconess Medical Center | Recruiting | No outcome recorded |
| Phase 4 | NCT04957368 | Nov 2021 → Feb 2024 | major depressive disorder | Unity Health Toronto | Completed | No outcome recorded |
| Phase 4 | NCT03941990 | Nov 2019 → Apr 2020 | anxiety | University Hospital, Clermont-Ferrand | Unknown | No outcome recorded |
| Phase 4 | NCT04083105 | Jul 2019 → Jul 2021 | — | Children's Hospital Colorado | Unknown | No outcome recorded |
| Phase 4 | NCT03847922 | Feb 2019 → Jul 2020 | female stress incontinence | Baylor Research Institute | Terminated | No outcome recorded |
| Phase 4 | NCT03228628 | Oct 2017 → Jun 2018 | anxiety | University Hospital, Clermont-Ferrand | Unknown | No outcome recorded |
| Phase 4 | NCT03435055 | Jul 2017 → Oct 2019 | — | University of Michigan | Completed | No outcome recorded |
| Phase 4 | NCT02985697 | Jan 2017 → Jan 2018 | — | Bon Secours Pediatric Dental Associates | Unknown | No outcome recorded |
| Phase 4 | NCT03365011 | Oct 2016 → Jun 2017 | tinnitus | Washington University School of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT02701478 | Jan → Dec 2016 | — | Maisonneuve-Rosemont Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02243826 | Jul 2014 → Oct 2015 | — | University Hospital, Clermont-Ferrand | Unknown | No outcome recorded |
| Phase 4 | NCT01087229 | Mar 2010 → Sep 2013 | frozen shoulder | Nîmes University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00967694 | Aug 2009 → Oct 2011 | glaucoma | Oregon Health and Science University | Completed | No outcome recorded |
| Phase 4 | NCT00834730 | Jan → Dec 2009 | — | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00547209 | Oct 2007 → Nov 2009 | — | Hopital Foch | Completed | No outcome recorded |
| Phase 4 | NCT02671578 | Nov 2006 → Nov 2007 | anxiety | Francisco Groppo | Completed | No outcome recorded |
| Phase 4 | NCT00321191 | May → Sep 2006 | — | Austin Health | Completed | No outcome recorded |
| Phase 4 | NCT00318825 | Apr 2006 → Sep 2008 | — | Rikshospitalet University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00146250 | Mar → Jul 2005 | — | Austin Health | Completed | No outcome recorded |
| Phase 4 | NCT00482456 | Jan 2005 → Mar 2007 | — | Medical University of Vienna | Completed | No outcome recorded |
| Phase 4 | NCT00164047 | Apr 2003 → Dec 2004 | — | Bayside Health | Completed | No outcome recorded |
| Phase not applicable24 trials | ||||||
| — | NCT07491874 | May 2026 → May 2028 expected | cervical incompetence | Kaplan Medical Center | Not yet recruiting | No outcome recorded |
| — | NCT07618676 | Jun 2025 → Jun 2026 overdue | anxiety | Institute for Oncology and Radiology of Serbia | Recruiting | No outcome recorded |
| — | NCT06557642 | Jul 2024 → Aug 2025 overdue | depressive disorder | University of Oxford | Recruiting | No outcome recorded |
| — | NCT05890898 | Sep 2023 → Jul 2024 | — | Geisinger Clinic | Completed | No outcome recorded |
| — | NCT05007028 | Nov 2021 → Dec 2024 | mental disorder | University Hospital, Tours | Completed | No outcome recorded |
| — | NCT04199143 | Feb 2020 → Jun 2021 | — | University Hospital, Tours | Completed | No outcome recorded |
| — | NCT04050267 | Apr 2019 | poisoning | Czech Technical University in Prague | Completed | No outcome recorded |
| — | NCT02886351 | Jan 2017 → Jan 2018 | anxiety | Bnai Zion Medical Center | Unknown | No outcome recorded |
| — | NCT03127371 | Sep 2016 → Apr 2021 | abscess | Albert Einstein Healthcare Network | Terminated | No outcome recorded |
| — | NCT02755090 | Jul 2016 → May 2017 | — | University of New Mexico | Completed | No outcome recorded |
| — | NCT02410707 | Feb 2015 → Feb 2018 | abscess | Albert Einstein Healthcare Network | Completed | No outcome recorded |
| — | NCT01616004 | Oct 2014 → Aug 2015 | — | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| — | NCT02145169 | Oct 2013 → Apr 2016 | — | Albert Einstein Healthcare Network | Completed | No outcome recorded |
| — | NCT01911351 | Jul 2013 → Jun 2014 | abscess | New York City Health and Hospitals Corporation | Completed | No outcome recorded |
| — | NCT01636999 | Sep 2012 → Sep 2014 | — | West Penn Allegheny Health System | Withdrawn | No outcome recorded |
| — | NCT01622335 | May 2012 → Dec 2022 | — | The Cleveland Clinic | Withdrawn | No outcome recorded |
| — | NCT01622322 | May 2012 → Dec 2023 | hernia, double inguinal | The Cleveland Clinic | Withdrawn | No outcome recorded |
| — | NCT01287052 | Jun 2011 → Aug 2014 | migraine disorder | Children's Hospitals and Clinics of Minnesota | Completed | No outcome recorded |
| — | NCT02024594 | Oct 2009 → Jul 2010 | anxiety disorder | Mashhad University of Medical Sciences | Completed | No outcome recorded |
| — | NCT00874172 | Oct 2009 → Oct 2012 | sickle cell disease | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| — | NCT00901394 | Mar 2009 → Jan 2010 | congenital anomaly of cardiovascular system | Washington University School of Medicine | Completed | No outcome recorded |
| — | NCT01022294 | Jan 2009 → Dec 2011 | dental pulp disorder | University of Aarhus | Completed | No outcome recorded |
| — | NCT00212147 | Sep 2003 → Aug 2008 | cognitive disorder, vitamin B deficiency | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Completed | No outcome recorded |
| — | NCT00000260 | Jun 1997 → Jan 1998 | substance-related disorder | University of Chicago | Completed | No outcome recorded |
Also used as a comparator or background therapy in 64 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03165500 Comparator | Dec 2015 → Dec 2016 | anxiety disorder | São Paulo State University | Completed | No outcome recorded |
| Phase 12 trials | ||||||
| Phase 1 | NCT06867068 Comparator | Oct 2016 → Jun 2024 | — | Albert Einstein College of Medicine | Completed | No outcome recorded |
| Phase 1 | NCT01581450 Comparator | Jan → Apr 2012 | — | Air Liquide | Completed | No outcome recorded |
| Phase 211 trials | ||||||
| Phase 2 | NCT05710887 Comparator | Feb 2026 | major depressive disorder | University of Chicago | Withdrawn | No outcome recorded |
| Phase 2 | NCT06118567 Comparator | Sep 2022 → Aug 2027 expected | intermittent explosive disorder | Ohio State University | Recruiting | No outcome recorded |
| Phase 2 | NCT05357066 Comparator | Nov 2021 → Feb 2026 | fibromyalgia | University of Chicago | Withdrawn | No outcome recorded |
| Phase 2 | NCT05357040 Comparator | Jun 2021 → Feb 2026 | major depressive disorder | University of Chicago | Withdrawn | No outcome recorded |
| Phase 2 | NCT02351869 Comparator | Aug 2015 → Feb 2020 | bipolar disorder | Sunnybrook Health Sciences Centre | Terminated | No outcome recorded |
| Phase 2 | NCT00000255 Comparator | Apr 1995 → May 1996 | substance-related disorder | University of Chicago | Completed | No outcome recorded |
| Phase 2 | NCT00000254 Comparator | Jan → Sep 1995 | substance-related disorder | University of Chicago | Completed | No outcome recorded |
| Phase 2 | NCT00000252 Comparator | Jun 1994 → Jun 1996 | substance-related disorder | University of Chicago | Completed | No outcome recorded |
| Phase 2 | NCT00000251 Comparator | Apr 1994 → Jan 1996 | substance-related disorder | University of Chicago | Completed | No outcome recorded |
| Phase 2 | NCT00000250 Comparator | Dec 1993 → May 1995 | substance-related disorder | University of Chicago | Completed | No outcome recorded |
| Phase 2 | NCT00000249 Comparator | Sep 1993 → Jun 1995 | substance-related disorder | University of Chicago | Completed | No outcome recorded |
| Phase 36 trials | ||||||
| Phase 3 | NCT05126459 Background | Feb 2022 → Apr 2023 | anxiety, dental caries | Loma Linda University | Completed | No outcome recorded |
| Phase 3 | NCT03879538 Comparator | Jul 2019 → Jul 2022 | complex regional pain syndrome | The Cleveland Clinic | Completed | No outcome recorded |
| Phase 3 | NCT03525821 Background | Jul 2018 → Sep 2020 | — | Fondation Lenval | Completed | No outcome recorded |
| Phase 3 | NCT01735669 Comparator | Jul 2012 → Apr 2013 | neonatal compartment syndrome, pregnancy disorder | Hospital de Cruces | Completed | No outcome recorded |
| Phase 3 | NCT00948103 Comparator | Sep 2008 → Dec 2011 | miliaria vesiculosa | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 3 | NCT00781352 Comparator | Nov 1998 → Nov 2003 | colorectal cancer | The Cleveland Clinic | Completed | No outcome recorded |
| Phase 412 trials | ||||||
| Phase 4 | NCT05396144 Comparator | May 2024 → Aug 2025 | — | Stanford University | Withdrawn | No outcome recorded |
| Phase 4 | NCT05883332 Comparator | Jan → Mar 2023 | — | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT05430750 Comparator | Jun 2022 → Apr 2023 | — | Sir Ganga Ram Hospital | Completed | No outcome recorded |
| Phase 4 | NCT05803096 Comparator | Dec 2021 → Sep 2022 | anxiety, benign prostatic hyperplasia, prostate adenocarcinoma | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT03467750 Background | Jul 2018 → Aug 2023 | obstructive sleep apnea syndrome | Emory University | Completed | No outcome recorded |
| Phase 4 | NCT03513757 Background | Mar → Aug 2018 | epilepsy, headache disorder, hydrocephalus, neoplasm +1 | Medical College of Wisconsin | Completed | No outcome recorded |
| Phase 4 | NCT03085563 Comparator | May 2017 → Nov 2018 | — | University of Colorado, Denver | Completed | No outcome recorded |
| Phase 4 | NCT02703233 Comparator | Mar 2016 → Mar 2018 | abscess | Christiana Care Health Services | Withdrawn | No outcome recorded |
| Phase 4 | NCT02489097 Comparator | Sep 2013 → May 2016 | cognitive disorder | University Hospital, Geneva | Terminated | No outcome recorded |
| Phase 4 | NCT01705743 Comparator | Sep 2012 → Sep 2013 | — | Huazhong University of Science and Technology | Completed | No outcome recorded |
| Phase 4 | NCT00706277 Comparator | Jun → Dec 2008 | — | Medical University Innsbruck | Completed | No outcome recorded |
| Phase 4 | NCT00226837 Comparator | Aug 2004 → Aug 2005 | — | Melbourne Health | Completed | No outcome recorded |
| Phase not applicable32 trials | ||||||
| — | NCT07473206 Comparator | Mar → Sep 2026 expected | — | Ospedale degli Infermi di Biella | Recruiting | No outcome recorded |
| — | NCT06539013 Comparator | Aug → Sep 2024 overdue | — | Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital | Recruiting | No outcome recorded |
| — | NCT07557576 Background | May 2024 → Aug 2026 overdue | cleft lip/palate | Iva Smiljanić | Recruiting | No outcome recorded |
| — | NCT05388942 Comparator | Oct 2022 → Oct 2023 | — | Reims University Hospital | Unknown | No outcome recorded |
| — | NCT05510141 Comparator | Aug 2022 → Oct 2024 | — | Insel Gruppe AG, University Hospital Bern | Unknown | No outcome recorded |
| — | NCT05167331 Comparator | Feb 2022 → Nov 2024 | — | University Hospital, Strasbourg, France | Terminated | No outcome recorded |
| — | NCT04008628 Comparator | Dec 2021 → Aug 2023 | — | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| — | NCT04749043 Comparator | Feb 2021 → Dec 2023 | — | Brendan Carvalho | Completed | No outcome recorded |
| — | NCT04310748 Comparator | May → Oct 2020 | — | Bezmialem Vakif University | Completed | No outcome recorded |
| — | NCT03956264 Comparator | Sep 2019 → Jul 2020 | cardiac valvular defect | CMC Ambroise Paré | Completed | No outcome recorded |
| — | NCT04185233 Comparator | Apr 2018 → May 2020 | anxiety | University Hospital, Geneva | Completed | No outcome recorded |
| — | NCT03420586 Comparator | Feb 2018 → Jul 2021 | — | General Hospital Zadar | Completed | No outcome recorded |
| — | NCT02783508 Comparator | Aug 2016 → May 2019 | — | HaEmek Medical Center, Israel | Completed | No outcome recorded |
| — | NCT02534012 Background | May 2016 → Apr 2022 | — | Makassed General Hospital | Unknown | No outcome recorded |
| — | NCT02736604 Comparator | May → Nov 2016 | female breast carcinoma | Tata Memorial Hospital | Completed | No outcome recorded |
| — | NCT02460055 Comparator | Mar → Jun 2016 | lung disorder | Baylor College of Medicine | Withdrawn | No outcome recorded |
| — | NCT02326727 Comparator | Apr 2015 → Apr 2017 | colonic neoplasm | Hillel Yaffe Medical Center | Unknown | No outcome recorded |
| — | NCT02355678 Background | Jan → Aug 2015 | — | Makassed General Hospital | Completed | No outcome recorded |
| — | NCT02236260 Background | Sep 2014 → Jun 2017 | Parkinson disease | Nantes University Hospital | Completed | No outcome recorded |
| — | NCT02005354 Comparator | Feb → Dec 2014 | — | University Hospital Plymouth NHS Trust | Completed | No outcome recorded |
| — | NCT02050152 Comparator | May → Oct 2013 | amnestic disorder | State University of New York at Buffalo | Completed | No outcome recorded |
| — | NCT02109510 Comparator | Nov 2012 → Sep 2013 | pneumothorax | Korea University | Completed | No outcome recorded |
| — | NCT00717574 Comparator | Mar 2008 → Oct 2010 | — | University of Oklahoma | Completed | No outcome recorded |
| — | NCT00655980 Comparator | Feb 2008 → Dec 2016 | coronary artery disorder | Washington University School of Medicine | Completed | No outcome recorded |
| — | NCT00000264 Comparator | Sep 1997 → Oct 1999 | substance-related disorder | University of Chicago | Completed | No outcome recorded |
| — | NCT00000263 Comparator | Jan 1997 → Oct 1998 | substance-related disorder | University of Chicago | Completed | No outcome recorded |
| — | NCT00000262 Comparator | Nov 1996 → Feb 1999 | substance-related disorder | University of Chicago | Completed | No outcome recorded |
| — | NCT00000259 Comparator | Aug 1996 → Nov 1997 | substance-related disorder | University of Chicago | Completed | No outcome recorded |
| — | NCT00000258 Comparator | Apr 1996 → Nov 1997 | substance-related disorder | University of Chicago | Completed | No outcome recorded |
| — | NCT00000257 Comparator | Sep 1995 → Apr 1997 | alcohol-related disorders | University of Chicago | Completed | No outcome recorded |
| — | NCT00000256 Comparator | Aug 1995 → Nov 1996 | substance-related disorder | University of Chicago | Completed | No outcome recorded |
| — | NCT00000253 Comparator | Nov 1994 → Mar 1996 | substance-related disorder | University of Chicago | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 157 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nitrous oxide | “Nitrous oxide inhalation was preferable to injectable ketamine for pediatric patients because it is safe, allows for a faster recovery, maintains sufficient sedation time, and...” PMID 23187987 ↗ Dec 2012137“Nitrous oxide (N2O) has been used since the 19th century for its analgesic, antinociceptive and anxiolytic effects during surgical procedures in awake and anaesthetised patients.” PMID 33399383 ↗ May 2021 “All patients will receive injectable paracetamol for pain relief, a mix of nitrous oxide 50% and oxygen 50% for analgesia and lidocaine hydrochloride for local anesthesia.” NCT02236260 ↗ “Anesthesia is maintained by 1-1.5% sevoflurane, 0.5 µg/kg/h fentanyl, 0.05 mg/kg/h nimbex, 60% nitrous oxide and 40% oxygen.” NCT02534012 ↗ “The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide.” NCT00000250 ↗ “The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide.” NCT00000253 ↗ “The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide.” NCT00000257 ↗ “The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide.” NCT00000256 ↗ “The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide.” NCT00000249 ↗ “Nitrous oxide, an inhalant agent used extensively In anesthesia, also have antagonist property of NMDA receptors.” NCT02246517 ↗ “administeration via inhalation of Nitrous oxide/oxygen (30-50% N2O/ 70-50% O2) via inhalation” NCT05126459 ↗ “Maintenance with sevoflurane 1-3%, fentanyl (1-2 µg kg-1), nitrous oxide 70% and oxygen 30%.” NCT02355678 ↗ “New interest in the psychiatric benefits of nitrous oxide (N2O) has only recently emerged.” PMID 40669910 ↗ Jul 2025 “Equimolar Mixture of Oxygen and Nitrous Oxide (50%O2 / 50%N2O) Active drug: Nitrous Oxide” NCT06382389 ↗ “All patients will undergo inhalational induction with nitrous oxide and sevoflurane.” NCT03467750 ↗ “Researchers will compare ENTONOX (50% nitrous oxide: 50% oxygen) with medical air.” NCT06557642 ↗ “The reduction of the fracture will be done under inhalation of nitrous oxide” NCT03525821 ↗ “Active Drug: EMONO (Equimolar Mixture of Oxygen and Nitrous Oxide)” NCT05007028 ↗ “Gas mixture composed of 50% Nitrous Oxide and 50% Oxygen” NCT03956264 ↗ “a gas mixture composed of 50% Nitrous Oxide, 50% Oxygen” NCT03483194 ↗ “Nitrous oxide inhalation with initial output of 9 L/min” NCT00874172 ↗ “Nitrous oxide is a widely used general anesthetic pas.” NCT00717574 ↗ “uptake of nitrous oxide (N2O) by the lungs” NCT00321191 ↗ |
| Known as | EMONO | “We hypothesized that the antidepressant response to an Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) would be associated with changes in cerebral connectivity and brain...” PMID 37592013 ↗ Aug 2023 |
| Known as | Inhaled nitrous oxide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07491874 ↗ |
| Known as | Laughing gas | “Nitrous oxide, commonly known as laughing gas, is a colorless, non-flammable gas with a slightly sweet odor, used for its analgesic and anesthetic properties in medical and...” NCT06498908 ↗2“There are some compelling reasons to question the routine use of nitrous oxide (N2O), also known as "laughing gas".” NCT00164047 ↗ “Inhalation of Nitrous oxide (Laughing gas) + intravenous saline” NCT07262008 ↗ |
| Known as | N2O | “Patients receive inhaled nitrous oxide (N₂O) administered through a buccal-nasal mask starting approximately 5 minutes before the outpatient hysteroscopy procedure and...” NCT07473206 ↗38“Nitrous oxide (N(2)O) has the advantages of being a sedative agent that does not require a painful injection and that offers shallower levels of sedation and a rapid recovery...” PMID 23187987 ↗ Dec 2012 “Women were assigned according to a balanced (1:1) restricted randomization design to inhale either nitrous oxide (N2 O) in a 50:50 mix with oxygen or medical air during the procedure.” PMID 31630398 ↗ Nov 2019 “an alternative method of providing analgesia with "on-demand" inhalation of nitrous oxide (hereafter referred to as N2O) combined with oxygen has been postulated.” NCT04305158 ↗ “Nitrous oxide (N2O) may offer a new therapeutic avenue with rapid and safe antidepressant effects in late-life depression with inadequate antidepressant response.” PMID 42005916 ↗ Apr 2026 “Nitrous oxide (N2O) is used as an inhalative gas during anesthesia, labour and at some dentist practices, most frequent in a fixed 50:50 combination with O2.” NCT00318825 ↗ “different concentrations of nitrous oxide (N2O) have different antidepressant effects for adults with treatment-resistant major depression.” NCT03283670 ↗ “This study aims at investigating the persistence of antidepressant effect of Nitrous Oxide (N2O) for Treatment-Resistant Depression(TRD).” NCT03932825 ↗ “This study is designed to evaluate the analgesic effect of nitrous oxide (N2O) on the pain induced during lumbar puncture.” NCT02243826 ↗ “Several lines of reasoning suggest that nitrous oxide (N2O) is an ideal medication to study as a potential treatment” PMID 32637725 ↗ Jun 2020 “Nitrous oxide (N2O) is a gas that is normally used to take away pain and anxiety during painful medical procedures.” NCT01785030 ↗ “There are some compelling reasons to question the routine use of nitrous oxide (N2O), also known as "laughing gas".” NCT00164047 ↗ “Nitrous oxide (N2O) has analgesic and sedative properties but may potentially increase the incidence of PONV.” NCT02736604 ↗ “Nitrous oxide (N2O) anesthesia may be associated with an increased risk of adverse cardiovascular outcomes.” NCT00655980 ↗ “Nitrous oxide (N2O) has analgesic and anxiolytic properties that are known for more than a century.” NCT03941990 ↗ “Nitrous oxide (N2O) has analgesic and anxiolytic properties that are known for more than a century.” NCT03228628 ↗ “New interest in the psychiatric benefits of nitrous oxide (N2O) has only recently emerged.” PMID 40669910 ↗ Jul 2025 “Nitrous oxide (N2O) has been used for the treatment of labor pains for over 150 years.” NCT01636999 ↗ “Nitrous oxide (N2O) was first isolated in 1772 by the English chemist Joseph Priestly” NCT06661005 ↗ “Patients were randomized to nitrous oxide (N(2)O)-based or N(2)O-free anaesthesia.” PMID 18682411 ↗ Aug 2008 “Ventilation of the patients was provided with a mixture of 40% oxygen and 60% N2O.” NCT04310748 ↗ “Nitrous oxide (N2O) offers both hypnotic and analgesic characteristics.” PMID 24486835 ↗ Jan 2014 “nitrous oxide (N2O, a common anesthetic agent)” NCT00212147 ↗ “Nitrous oxide (N2O) is a way of treating pain” NCT01891812 ↗ “Nitrous oxide (N2O/O2) for pain alleviation” NCT05579288 ↗ “Nitrous oxide (N2O) is a greenhouse gas” NCT05430750 ↗ “20% inhaled N2O” NCT00000249 ↗ “N2O” NCT02899182 ↗ |
| Known as | Nitrous Oxide + Oxygen Gas | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03847922 ↗ |
| Known as | Nitrous Oxide-Oxygen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02024594 ↗ |
| Known as | SANO | “Whether self-administered low dose (20-45%) nitrous oxide (SANO) reduces intraoperative anxiety and catastrophizing during office vasectomy.” NCT07245628 ↗ |
| Action | Inhibit | “N2O inhibits vitamin B12-dependent enzymes” NCT00655980 ↗ |
| Modality | Other / unclassified | “Nitrous oxide (N2O) is a gas that is normally used to take away pain and anxiety during painful medical procedures.” NCT01785030 ↗ |
| Route | Inhaled | “20% inhaled N2O” NCT00000249 ↗ |